BevCanna Enterprises Inc. (BVNNF)
USD 0.49
(2119.46%)
USD 0.49
(2119.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.06 Million | -600.58 Thousand | -5.6 Million | -1.8 Million | -3.96 Million | -570.87 Thousand |
| Net Income | -5.37 Million | -12.43 Million | -78.17 Million | -11.18 Million | -7.85 Million | -5.1 Million |
| Depreciation & Amortization | 500.6 Thousand | 616.35 Thousand | 1.94 Million | 1.14 Million | 961.04 Thousand | 503.26 Thousand |
| Deferred income taxes | - | 2.55 Million | -3.36 Million | -4.52 Million | - | - |
| Stock-based compensation | - | 229.72 Thousand | 892.24 Thousand | 2.15 Million | 2.73 Million | - |
| Change in working capital | 3.08 Million | 4.1 Million | 1.31 Million | 2.04 Million | 808.7 Thousand | 190.5 Thousand |
| Other non-cash items | -2.27 Million | 4.31 Million | 71.77 Million | 8.56 Million | 4.28 Million | 4.86 Million |
| Investing Cash Flow | -4753.35 | 527.71 Thousand | -672.33 Thousand | -301.11 Thousand | -2.72 Million | -3.45 Million |
| Investments in PPE | -4753.35 | -188.8 Thousand | -838.17 Thousand | -735.23 Thousand | -2.47 Million | -4.55 Million |
| Acquisitions | - | 716.51 Thousand | 18.67 Thousand | 400.94 Thousand | - | 1.09 Million |
| Investment purchases | - | - | 1.07 | - | -424.13 Thousand | - |
| Sales/Maturities of investments | - | - | 143.74 Thousand | 33.18 Thousand | 179.35 Thousand | - |
| Other Investing Activities | - | -1.00 | 3420.93 | 1.00 | -244.45 Thousand | - |
| Financing Cash Flow | 1.07 Million | 20.28 Thousand | 5.61 Million | 2.84 Million | 1.63 Million | 8.89 Million |
| Debt repayment | -1.42 Million | - | -217.04 Thousand | -31.39 Thousand | -485.82 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -197.65 Thousand | - | -232 Thousand | - |
| Common Stock Issuance | 1.07 Million | 20.28 Thousand | 6.01 Million | 2.81 Million | 1.37 Million | 8.89 Million |
| Other Financing Activities | 916.19 Thousand | 5539.35 | 15.81 Thousand | 1.34 Million | 946.53 Thousand | - |
| Accounts receivables | 221.07 Thousand | -47.73 Thousand | -335.98 Thousand | -80.67 Thousand | -238.43 Thousand | -13.63 Thousand |
| Accounts payables | 3.69 Million | 3.98 Million | 2.07 Million | 3.02 Million | - | - |
| Inventory | 91.64 Thousand | 88.32 Thousand | -312.77 Thousand | -3.02 Million | - | - |
| Other working capital | -919.6 Thousand | 88.83 Thousand | -107.69 Thousand | 2.12 Million | 1.04 Million | 204.14 Thousand |
| Cash at beginning of period | 100.18 Thousand | 182.05 Thousand | 812.04 Thousand | 68.62 Thousand | 4.86 Million | - |
| Cash at end of period | 105.03 Thousand | 100.18 Thousand | 182.05 Thousand | 812.04 Thousand | 68.62 Thousand | 4.86 Million |
| Capital Expenditure | -4753.35 | -188.8 Thousand | -838.17 Thousand | -735.23 Thousand | -2.47 Million | -4.55 Million |
| Effect of forex changes on cash | 2965.00 | -23.19 Thousand | 30.6 Thousand | -2152.00 | -0.84 | - |
| Net cash flow / Change in cash | 4857.00 | -81.87 Thousand | -629.98 Thousand | 743.42 Thousand | -4.79 Million | 4.86 Million |
| Free Cash Flow | -1.07 Million | -789.38 Thousand | -6.44 Million | -2.53 Million | -6.44 Million | -5.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.26 Million | -1.1 Million | -7.89 Million | -5.37 Million | -1.23 Million | -995.52 Thousand |
| Depreciation & Amortization | 133.4 Thousand | 94.85 Thousand | 84.63 Thousand | 500.6 Thousand | 142.1 Thousand | 145.64 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.57 Million | 1.2 Million | 243.66 Thousand | 3.08 Million | 1 Million | 893.55 Thousand |
| Other non-cash items | -271.32 Thousand | -1.77 Million | 5.65 Million | -2.27 Million | 69.1 Thousand | 29.2 Thousand |
| Investing Cash Flow | - | - | - | -4753.35 | 1.47 | -4754.23 |
| Investments in PPE | 562.63 Thousand | - | - | -4753.35 | 1.47 | -4754.23 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 551.12 Thousand | 599.46 Thousand | 1.21 Million | 1.07 Million | -132.81 Thousand | -14.93 Thousand |
| Debt repayment | -776.05 Thousand | -812.06 Thousand | - | -1.42 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -220.71 Thousand | 599.46 Thousand | - | 1.07 Million | - | - |
| Other Financing Activities | 760 Thousand | 570.93 Thousand | - | 916.19 Thousand | - | - |
| Accounts receivables | -82.28 Thousand | -21.91 Thousand | - | 221.07 Thousand | 234.42 Thousand | -26.78 Thousand |
| Accounts payables | 1.56 Million | 1.17 Million | - | 3.69 Million | 455.61 Thousand | 805.28 Thousand |
| Inventory | 47.15 Thousand | -45.18 Thousand | -169.53 Thousand | 91.64 Thousand | 85.53 Thousand | 158.33 Thousand |
| Other working capital | 53.12 Thousand | 96.61 Thousand | -1.09 Million | -919.6 Thousand | 231.31 Thousand | -43.27 Thousand |
| Cash at beginning of period | 59.29 Thousand | 115.7 Thousand | 157.19 Thousand | 100.18 Thousand | 140.22 Thousand | 70.89 Thousand |
| Cash at end of period | 43.24 Thousand | 59.29 Thousand | 139.21 Thousand | 105.03 Thousand | 115.7 Thousand | 140.22 Thousand |
| Capital Expenditure | 562.63 Thousand | - | - | -4753.35 | 1.47 | -4754.23 |
| Effect of forex changes on cash | -5392.00 | 3338.00 | -132.83 Thousand | 2965.00 | 132.81 Thousand | -318.00 |
| Net cash flow / Change in cash | -16.04 Thousand | -56.41 Thousand | -17.97 Thousand | 4857.00 | -24.51 Thousand | 69.32 Thousand |
| Free Cash Flow | - | -645.4 Thousand | -1.23 Million | -1.07 Million | -21.31 Thousand | 68.12 Thousand |
ARTEMISMED
AUMC
PEB-PG
002378
MASN
7TEC